Pharmacologic management of diabetic peripheral neuropathic pain (Q38116975)

29 August 2017

Pharmacologic management of diabetic peripheral neuropathic pain (English)

1 reference

29 August 2017

0 references

0 references

Shridhar Iyer

1

1 reference

PubMed ID

23800105

29 August 2017

Robert J Tanenberg

series ordinal

2

1 reference

PubMed ID

23800105

29 August 2017

language of work or name

English

0 references

publication date

26 June 2013

1 reference

Expert Opinion on Pharmacotherapy

29 August 2017

1 reference

29 August 2017

14

1 reference

29 August 2017

13

1 reference

29 August 2017

1765-1775

1 reference

Relationship between risk factors and mortality in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study (PCS).

29 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.811490

Prevalence of polyneuropathy in pre-diabetes and diabetes is associated with abdominal obesity and macroangiopathy: the MONICA/KORA Augsburg Surveys S2 and S3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.811490

Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.811490

Diabetic neuropathy: mechanisms to management

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.811490

Effect of hyperglycemia on pain threshold in alloxan-diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.811490

Diabetes and the peripheral nerve

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.811490

Aldose reductase inhibitors in the treatment of diabetic peripheral neuropathy: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.811490

Continuous subcutaneous insulin infusion in the management of painful diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.811490

Development of ongoing activity, mechanosensitivity, and adrenaline sensitivity in severed peripheral nerve axons

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.811490

Painful diabetic peripheral neuropathy: consensus recommendations on diagnosis, assessment and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.811490

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.811490

Insights from the diabetes control and complications trial/epidemiology of diabetes interventions and complications study on the use of intensive glycemic treatment to reduce the risk of complications of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.811490

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.811490

Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.811490

Diabetic neuropathy: clinical manifestations and current treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.811490

Increased intake of calcium reverses vitamin B12 malabsorption induced by metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.811490

Risk Factors of Vitamin B12 Deficiency in Patients Receiving Metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.811490

Metformin-Associated Vitamin B12 Deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.811490

Metformin and vitamin B12 deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.811490

Nicotinamide reverses neurological and neurovascular deficits in streptozotocin diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.811490

Painful diabetic neuropathy: advantage of novel drugs over old drugs?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.811490

Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.811490

Diabetic somatic neuropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.811490

Anticonvulsant drugs for management of pain: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.811490

Lamotrigine reduces painful diabetic neuropathy: a randomized, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.811490

Topiramate vs placebo in painful diabetic neuropathy: analgesic and metabolic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.811490

Sodium valproate in the management of painful neuropathy in type 2 diabetes - a randomized placebo controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.811490

Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.811490

Gabapentin in the treatment of painful diabetic neuropathy: a placebo controlled, double blind, crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.811490

Outcome reporting in industry-sponsored trials of gabapentin for off-label use

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.811490

3-substituted GABA analogs with central nervous system activity: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.811490

A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.811490

A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.811490

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.811490

Duloxetine for the management of diabetic peripheral neuropathic pain: evidence-based findings from post hoc analysis of three multicenter, randomized, double-blind, placebo-controlled, parallel-group studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.811490

Duloxetine vs. placebo in patients with painful diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.811490

Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.811490

Efficacy, safety, and tolerability of pregabalin treatment for painful diabetic peripheral neuropathy: findings from seven randomized, controlled trials across a range of doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.811490

Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.811490

Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.811490

Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.811490

Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: a randomized, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.811490

Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.811490

The adverse event profile of pregabalin: a systematic review and meta-analysis of randomized controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.811490

Duloxetine, pregabalin, and duloxetine plus gabapentin for diabetic peripheral neuropathic pain management in patients with inadequate pain response to gabapentin: an open-label, randomized, noninferiority comparison.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.811490

Conditioned pain modulation predicts duloxetine efficacy in painful diabetic neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.811490

Management of painful diabetic neuropathy: guideline guidance or jungle?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.811490

EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.811490

A cost-utility analysis of pregabalin versus duloxetine for the treatment of painful diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.811490

Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.811490

Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.811490

Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.811490

Rab7 silencing prevents μ-opioid receptor lysosomal targeting and rescues opioid responsiveness to strengthen diabetic neuropathic pain therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.811490

Sustained-release oxycodone tablets for moderate to severe painful diabetic peripheral neuropathy: a multicenter, open-labeled, postmarketing clinical observation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.811490

Topical Capsaicin in Painful Diabetic Neuropathy: Controlled Study With Long-Term Follow-Up

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.811490

Randomized control trial of topical clonidine for treatment of painful diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.811490

IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.811490

Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U.K.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.811490

Burden of illness associated with painful diabetic peripheral neuropathy among adults seeking treatment in the US: results from a retrospective chart review and cross-sectional survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2013.811490

10.1517/14656566.2013.811490

21 January 2018

Identifiers

DOI

1 reference

29 August 2017

1 reference

PubMed ID

23800105